2D·

Novo Nordisk suddenly seems surprisingly... desperate.

When a billion-dollar company like $NOVO B (+0.61%) suddenly starts throwing around such cheap advertising, you can see it immediately:

Someone is trying to artificially boost the share price.

attachment
5
11 Comments

profile image
I'm no marketing expert, but anyone who doesn't use social media as an advertising platform is simply ignoring a large potential advertising market. Especially since potential customers are likely to spend a lot of time using social channels, I find your thesis rather amusing instead of the other way around...
36
profile image
@Brateeee hope you didn't buy novo 🤫
Said the boy with the Pokemon cards
8
profile image
I think it's really nice that you rate pharmaceutical companies with an advertisement *yikes*. Assuming you're in the medical field, you really know a lot about the company and what's going on there. It's also obvious that you have a lot of experience in the stock market. A little tip: you can make money with any company, it depends on when you buy and every company has ups and downs and every company corrects after a while, it has always been like that and it will always be like that.
6
It's amazing what alleged causal connections you recognize here, you seem to be called to higher things.
There are many people here who have a lot of expertise and then there are you, where I have to laugh at every post and comment because you so obviously display your ignorance 😕
2
How can you be done with life like you 😂
profile image
I've often heard the word "chip shop" in connection with Novo, I think that's completely true😀
@juliana-investment this usually comes from those who are invested and are very heavily in the red and don't want to admit it. 😀
profile image
That's true😀 but I hardly think that someone is in Plus
Sales figures for pharmaceutical companies are product-specific. Take Bayer with aspirin, for example. Social media has little relevance here if it does not relate to the product itself
profile image
What do you think?
Join the conversation